Microtriplication 11q24.1 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:289522Q99.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Microtriplication 11q24.1 syndrome (Orphanet code 289522) is an extremely rare chromosomal condition in which a small segment of chromosome 11, specifically the region called 11q24.1, is present in three extra copies instead of the normal two. This means there is a triplication — three additional copies — of genetic material in that area. Because this region contains genes that play roles in development, having extra copies can disrupt normal growth and brain development. Because so few cases have been reported in the medical literature, the full range of symptoms is not yet well understood. However, based on available reports, individuals with this condition may experience developmental delay, intellectual disability, speech and language difficulties, and certain physical features that may be subtle. Some patients may also have behavioral differences or learning challenges. There is currently no cure or specific treatment for this syndrome. Management focuses on supportive care tailored to each person's symptoms. This may include speech therapy, occupational therapy, physical therapy, special education services, and regular developmental monitoring. Early intervention programs can help children reach their full potential. Because the condition is so rare, families are encouraged to work closely with a clinical geneticist and a multidisciplinary team to create an individualized care plan.

Also known as:

Key symptoms:

Developmental delayIntellectual disabilitySpeech and language delaysLearning difficultiesBehavioral differencesMild unusual facial featuresMotor skill delaysDifficulty with coordinationAttention problemsSocial interaction challenges

Clinical phenotype terms (39)— hover any for plain English
KeratoconusHP:0000563Metatarsus adductusHP:0001840
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Microtriplication 11q24.1 syndrome.

View clinical trials →

No actively recruiting trials found for Microtriplication 11q24.1 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Microtriplication 11q24.1 syndrome community →

No specialists are currently listed for Microtriplication 11q24.1 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Microtriplication 11q24.1 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Microtriplication 11q24.1 syndromeForum →

No community posts yet. Be the first to share your experience with Microtriplication 11q24.1 syndrome.

Start the conversation →

Latest news about Microtriplication 11q24.1 syndrome

No recent news articles for Microtriplication 11q24.1 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size and location of the triplication, and which genes are involved?,Was this triplication inherited from a parent or did it occur as a new change?,What developmental screenings and therapies should we start right away?,How often should my child be evaluated by a developmental specialist?,Are there any other medical tests or evaluations we should do to check for related health issues?,Should other family members be tested for this chromosomal change?,Are there any research studies or registries we can participate in?

Common questions about Microtriplication 11q24.1 syndrome

What is Microtriplication 11q24.1 syndrome?

Microtriplication 11q24.1 syndrome (Orphanet code 289522) is an extremely rare chromosomal condition in which a small segment of chromosome 11, specifically the region called 11q24.1, is present in three extra copies instead of the normal two. This means there is a triplication — three additional copies — of genetic material in that area. Because this region contains genes that play roles in development, having extra copies can disrupt normal growth and brain development. Because so few cases have been reported in the medical literature, the full range of symptoms is not yet well understood.

At what age does Microtriplication 11q24.1 syndrome typically begin?

Typical onset of Microtriplication 11q24.1 syndrome is infantile. Age of onset can vary across affected individuals.